Riskpilot← Back to searchSign inGet full accessAPOTEKGÅRDEN LIER AS
ASActiveOrg 916711158Vestsideveien 9E, 3403 LierRental and operating of own or leased real estate · NACE 6820Est. 20160 employees
Revenue 2024
NOK 1,3M
+5% vs 2023
EBITDA margin
71.2%
-1% vs 2023
Equity ratio
3.2%
Financial strength
Net profit 2024
NOK 147K
-21% vs 2023
| Revenue | NOK 1,3M | +5% |
| EBITDA | NOK 960K | -1% |
| Net profit | NOK 147K | -21% |
| Total assets | NOK 10,2M | -5% |
| Equity | NOK 321K | +21% |
| Employees | 0 | — |
Legal name
APOTEKGÅRDEN LIER AS
Org number
916711158
Legal form
Aksjeselskap
NACE code
6820 · Rental and operating of own or leased real estate
Founded
17. februar 2016
Share capital
NOK 100 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Å utøve næringsvirksomhet ved erverv og drift/salg av fast eiendom, deltagelse i andre foretak og det som naturlig står i forbindelse hermed. Samt investeringer og aksjer.
Address
Vestsideveien 9E, 3403 Lier
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 1 083 | 1 113 | 1 192 | 1 282 | 1 348 |
| Staff expenses | −0 | −0 | −17 | −0 | −0 |
| EBITDA | 816 | 817 | 930 | 966 | 960 |
| Depreciation & amort. | −126 | −126 | −126 | −126 | −130 |
| EBIT | 690 | 691 | 805 | 840 | 829 |
| Net financials | −261 | −269 | −391 | −601 | −640 |
| Profit before tax | 429 | 422 | 414 | 239 | 189 |
| Tax | 94 | 93 | 92 | 53 | 42 |
| Net profit | 334 | 329 | 322 | 186 | 147 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 13 030 | 12 871 | 12 487 | 10 765 | 10 178 |
| Equity | 1 074 | 1 212 | 194 | 265 | 321 |
| Long-term debt | 11 777 | 11 241 | 10 691 | 10 136 | 9 577 |
| Short-term debt | 179 | 417 | 1 602 | 364 | 279 |
| Total debt | 11 957 | 11 659 | 12 293 | 10 500 | 9 856 |
EBITDA margin
71.2%
This company
15.8%
Market median
+351% vs market
20202024
Equity ratio
3.2%
This company
38.2%
Market median
-92% vs market
20202024
Return on equity
45.8%
This company
18.4%
Market median
+149% vs market
20202024
Net profit margin
10.9%
This company
8.1%
Market median
+35% vs market
20202024
Asset turnover
0.13×
This company
1.12×
Market median
-88% vs market
20202024
Debt / equity
30.66×
This company
0.62×
Market median
-4845% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
BH Deputy Member | Deputy Member | 2016 |
SW Deputy Member | Deputy Member | 2016 |
BB Deputy Member | Deputy Member | 2016 |
MW Deputy Member | Deputy Member | 2016 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2016 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Gigant Gruppen As
APOTEKGÅRDEN LIER AS Board members of APOTEKGÅRDEN LIER AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Barbara Halstensen | Deputy Member | 0 companies |
| Stian Waitz Halstensen | Deputy Member | 0 companies |
| Barbara Baklarz | Deputy Member | 0 companies |
| Martin Waitz Halstensen | Deputy Member | 0 companies |
| Rune Halstensen | Chairman | 0 companies |